SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Bharat Parenterals

BSE: 541096 29 Jun 2025
Healthcare
₹ 1111
Bharat Parenterals Limited specializes in Pharmaceuticals within the Healthcare sector.

Bharat Parenterals - Share Price & Details

Market Cap
₹786.0
High /Low
1,870 / 802.0
Stock P/E
29.7
Book Value
₹561.0
Dividend Yield
0.09
ROCE
11.0
ROE
₹8.81
Face Value
10.0
PEG Ratio
-270.0
EVEBITDA
₹17.1
Debt
64.8
CMP / FCF
-59.1
Debt to equity
₹0.17
NP Ann
26.4
High price all time
1,870
Piotroski score
₹5.0
Graham Number
696.0
No. Eq. Shares
0.69
Net CF
₹-1.22
Net profit
26.4
Price to book value
2.03
Interest Coverage
₹8.58
Low price all time
116.0
Industry PE
32.7
Reserves
₹380
Free Cash Flow
₹-0.63

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Bharat Parenterals LimitedNANANANA786.029.7
Shree Ganesh Remedies LimitedNANANANA77233.5
KILITCH DRUGS (INDIA) LTD.586.29113.74563.047.0769427.8

Peer Comparison Chart


About Bharat Parenterals

Bharat Parenterals Limited, with Security Code 541096, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Bharat Parenterals Faces Increased Selling Pressure Amid Consecutive Losses and Volatility

(08 Jun 2025)
Bharat Parenterals Ltd is experiencing notable selling pressure, following consecutive days of losses despite a prior gain streak. The stock has shown mixed...
Read more →

Has Bharat Parenter. declared dividend?

(07 Jun 2025)
Bharat Parenterals Ltd has declared a 10% dividend, amounting to ₹1 per share, with an ex-date of June 25, 2024. Recent total returns show a -22.1% return...
Read more →

5 Ashish Kacholia stocks that Mukul Agarwal secretly holds

(26 May 2025)
Kacholia and Agarwal, names that need no introduction in the investor circles of India. With hundreds of crores worth of portfolio,...
Read more →

Bharat Parenterals Limited recommends final dividend of Rs. 1

(14 May 2025)
The Board of Directors of Bharat Parenterals Limited have approved the recommendation of final dividend of Rs. 1.00/- per equity share of...
Read more →

Bharat Parenterals Reports Mixed Financial Results Amid Record Sales Growth in May 2025

(13 May 2025)
Bharat Parenterals announced its financial results for the quarter ending March 2025, revealing a significant year-on-year increase in net...
Read more →

Bharat Parenter Standalone March 2025 Net Sales at Rs 80.28 crore, up 22.3% Y-o-Y

(13 May 2025)
Quarterly Net Profit at Rs. 2.28 crore in March 2025 down 25.73% from Rs. 3.07 crore in March 2024. EBITDA stands at Rs. 6.86 crore in March...
Read more →